Highlander Capital Management, LLC Lexicon Pharmaceuticals, Inc. Transaction History

Highlander Capital Management, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 14, 2021	SELL	$3.45 - $9.09 $144 - $381	-42 Closed	0 $0
Q3 2020 Nov 17, 2020	BUY	$1.44 - $2.1 $60 - $88	42 New	42 $0
Q2 2020 Aug 17, 2020	SELL	$1.75 - $2.3 $73 - $96	-42 Closed	0 $0
Q1 2020 May 27, 2020	BUY	$1.8 - $4.28 $75 - $179	42 New	42 $0
Q3 2019 Nov 14, 2019	SELL	$1.2 - $6.66 $50 - $279	-42 Closed	0 $0

Q1 2019 May 15, 2019	BUY	$4.36 - $7.94 $183 - $333	42 New	42 $0
Q4 2018 Feb 14, 2019	SELL	$6.15 - $10.51 $258 - $441	-42 Closed	0 $0
Q2 2018 Aug 15, 2018	BUY	$7.8 - $13.69 $327 - $574	42 New	42 $1,000
Q1 2018 May 16, 2018	SELL	$7.86 - $11.39 $330 - $478	-42 Closed	0 $0
Q3 2017 Nov 15, 2017	BUY	$12.17 - $16.3 $511 - $684	42	42 $1,000

122

159M

2.11M

412K

Ticker LXRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 188,726,000
Market Cap $302M
Description
Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; ...

Get notified when there are updates to the investment portfolio of Highlander Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Highlander Capital Management, LLC with notifications on news.